Skip to content
10-Q

Quarterly Report

BIOSYNERGY INC

0000715812-20-000006

← back to feed
Filed
Sep 10, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Jul 31, 2020 14.94M sh
Cash And Equivalents Q1 2020 · Jul 31, 2020 $1.25M
Cash And Equivalents Q1 2020 · Apr 30, 2020 $1.25M
Cash And Equivalents Q1 2020 · Jul 31, 2019 $1.21M
Cash And Equivalents Q1 2020 · Apr 30, 2019 $1.18M
Stockholders Equity Q1 2020 · Jul 31, 2020 $1.71M
Stockholders Equity Q1 2020 · Apr 30, 2020 $1.72M
Current Liabilities Q1 2020 · Jul 31, 2020 $150.17K
Current Liabilities Q1 2020 · Apr 30, 2020 $166.79K
Current Assets Q1 2020 · Jul 31, 2020 $1.67M
Current Assets Q1 2020 · Apr 30, 2020 $1.7M
Total Assets Q1 2020 · Jul 31, 2020 $1.95M
Total Assets Q1 2020 · Apr 30, 2020 $2.01M
Operating Cash Flow Q1 2020 · Jul 31, 2019 $33.52K
Sga Expense Q1 2020 · Jul 31, 2019 $110.52K
Rd Expense Q1 2020 · Jul 31, 2019 $39.92K
Net Income Q1 2020 · Jul 31, 2019 $8.58K
Operating Income Q1 2020 · Jul 31, 2019 $11.37K
Gross Profit Q1 2020 · Jul 31, 2019 $209.61K